Medwatch sent to fda on 3/4/2016.(b)(4).The events of infection, seroma, fistula, scarring, and the device being difficult to remove are physiological complications, and analysis of the device generally does not assist allergan in determining a probable cause for these events.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Device labeling addresses the reported events of infection and fistula as follows: "adverse reactions are those typically associated with surgically implantable materials, including infection, inflammation, adhesion formation, fistula formation, and extrusion.".
|